Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tulasne

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
FEBS Letters|July 19, 2023
Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding siteMarie Fernandes, Sonia Paget, Zoulika Kherrouche, et al.
Elife|February 25, 2020
Control of cell death/survival balance by the MET dependence receptorLeslie Duplaquet, Catherine Leroy, Audrey Vinchent, et al.
Chemical Science|July 19, 2017
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent <i>in vivo</i> MET receptor agonistClaire Simonneau, Bérénice Leclercq, Alexandra Mougel, et al.
Molecular Oncology|February 21, 2025
MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulationCélia Guérin, Audrey Vinchent, Marie Fernandes, et al.
Molecular Carcinogenesis|August 3, 2019
Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotypeMehdi El Amrani, François Corfiotti, Matthieu Corvaisier, et al.
NPJ Precision Oncology|April 15, 2025
A coregulatory influence map of glioblastoma heterogeneity and plasticityChloé Bernhard, Konstantinos Geles, Geoffrey Pawlak, et al.
Molecular Cell|September 17, 2013
The dependence receptor TrkC triggers mitochondria-dependent apoptosis upon Cobra-1 recruitmentGabriel Ichim, Anne-Laure Genevois, Marie Ménard, et al.
Biorxiv : the Preprint Server for Biology|November 15, 2023
MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulationCélia Guérin, Audrey Vinchent, Marie Fernandes, et al.
Oncotarget|December 30, 2017
Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitorsSimon Baldacci, Julien Mazieres, Pascale Tomasini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm studySimon Baldacci, Martin Figeac, Martine Antoine, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
FEBS Letters|July 19, 2023
Transforming properties of MET receptor exon 14 skipping can be recapitulated by loss of the CBL ubiquitin ligase binding siteMarie Fernandes, Sonia Paget, Zoulika Kherrouche, et al.
Elife|February 25, 2020
Control of cell death/survival balance by the MET dependence receptorLeslie Duplaquet, Catherine Leroy, Audrey Vinchent, et al.
Chemical Science|July 19, 2017
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent <i>in vivo</i> MET receptor agonistClaire Simonneau, Bérénice Leclercq, Alexandra Mougel, et al.
Molecular Oncology|February 21, 2025
MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulationCélia Guérin, Audrey Vinchent, Marie Fernandes, et al.
Molecular Carcinogenesis|August 3, 2019
Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotypeMehdi El Amrani, François Corfiotti, Matthieu Corvaisier, et al.
NPJ Precision Oncology|April 15, 2025
A coregulatory influence map of glioblastoma heterogeneity and plasticityChloé Bernhard, Konstantinos Geles, Geoffrey Pawlak, et al.
Molecular Cell|September 17, 2013
The dependence receptor TrkC triggers mitochondria-dependent apoptosis upon Cobra-1 recruitmentGabriel Ichim, Anne-Laure Genevois, Marie Ménard, et al.
Biorxiv : the Preprint Server for Biology|November 15, 2023
MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulationCélia Guérin, Audrey Vinchent, Marie Fernandes, et al.
Oncotarget|December 30, 2017
Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitorsSimon Baldacci, Julien Mazieres, Pascale Tomasini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm studySimon Baldacci, Martin Figeac, Martine Antoine, et al.
Pageof 7